897.5000 -13.55 (-1.49%)
NSE Dec 29, 2025 15:30 PM
Volume: 184.0K
 

Geojit BNP Paribas
Strides reported its Q2FY22 revenue at Rs. 721cr, (4.8% QoQ, -9% YoY), enabled by a bounce back in the other regulated markets which was partially offset by an underperformance in the US markets. US markets (34% of total revenues) witnessed a 17% QoQ/-38% YoY...
Strides Pharma Science Ltd. is trading below its 30 day SMA of 906.1
More from Strides Pharma Science Ltd.
Recommended